title: [Systemic treatment of biliary tract cancer].
abstract: Biliary tract cancer is a relatively rare disease with a poor prognosis. The disease should be handled in a multidisciplinary setting to ensure proper diagnosis and curative surgery if possible. The majority of patients will, however, need oncologic treatment at a certain time. The standard treatment is combination chemotherapy with gemcitabine and a platinum, and in Denmark the regime consists of gemcitabine, oxaliplatin and capecitabine. Research is focused on tumour markers and clinical trials combining chemotherapy with molecularly targeted agents.
authors.affiliation: Onkologisk Afdeling, Vejle Sygehus, Kabbeltoft 25, 7100 Vejle. lars.henrik.jensen@slb.regionsyddanmark.dk.
authors.forename: Lars Henrik
authors.initials: LH
authors.lastname: Jensen
authors.forename: Ole
authors.initials: O
authors.lastname: Larsen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001650:Bile Duct Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D018281:Cholangiocarcinoma / Q000188:drug therapy*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods; D064847:Multimodal Imaging; D017063:Outcome Assessment, Health Care; D011877:Radionuclide Imaging